These data were confirmed by Montagna et al., who reported that genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families as evidenced by MLPA analysis [80]. The gene discussed is BRCA1; the disease is ovarian carcinoma.